Piper Jaffray Raises INFI Target From $6 To $9, Upgrades Shares To OW

BenzingaStaffL

May 09, 2011 7:22am Comments

Piper Jaffray is upgrading shares of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) from Neutral to Overweight while raising its PT from $6 to $9.

Infinity Pharmaceuticals closed Friday at $5.79.

Posted-In: Infinity Pharmaceuticals Piper Jaffray Upgrades Price Target Analyst Ratings

Need analyst data?
Click here to see licensing options.

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

1	XLK, QQQ: This Nasdaq 100 Signal Last Flashed In 1999—What Came Next Was Insane
2	HON: Honeywell Lifts Outlook As Transformation Picks Up Speed
3	SPY, QQQ: Federal Reserve Rates 'Justified' Despite Being Hig...
4	KO: Coke's Sweet Switch: Cane Sugar Beverage, Fairlife Ram...
5	THC, EFX: Lockheed, General Motors Tumble, Gold Hits 1-Month...
6	HFWA, OCFC: Earnings Scheduled For July 24, 2025
7	Japan PM Ishiba Resignation Seen As Inevi...

1	MASI: $1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
2	GOOG, GOOGL: Google Stock Roars As Analysts Race To Raise Price Targets
3	DJT, $BTC: Trump Media (DJT) Stock Pulls Back, Consolidating Recent...
4	GSK: GSK's Blood Cancer Drug Review Extended As FDA S...
5	A New Obesity Contender From China Targeting Same Rec...
6	LKQ: LKQ Shares Crash To 52-Week Low On Slashed Outlook
7	China's New Investment Playbook: VCs Chase Cr...

Market Overview